Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EnBio HoldingsTSE:6092 +1.11%58 Days Payable is 40.17 as of Mar. 2026, which is 5% below its 10-year median of 42.46. GuruFocus rates TSE:6092 with a GF Score™ of 58/100 and a GF Value™ of 円799.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 946 Business Services companies, EnBio Holdings ranks worse than 55.18% on this metric.
The historical rank and industry rank for EnBio Holdings's Days Payable or its related term are showing as below:
TSE:6092'
s Days Payable Range Over the Past 10 Years
Min: 32.36 Med: 42.46 Max: 51.45
Current: 39.74
During the past 13 years, EnBio Holdings's highest Days Payable was 51.45. The lowest was 32.36. And the median was 42.46.
TSE:6092's Days Payable is ranked worse than 55.18% of 946
companies
in the Business Services industry
Industry Median: 45.96
vs TSE:6092: 39.74
EnBio Holdings's Days Payable
increased
from Mar. 2025 (0.00) to Mar. 2026 (40.17).
It may suggest that EnBio Holdingsdelayed paying its suppliers.
EnBio Holdings Days Payable Related Terms
EnBio Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, ULS: Days Payable Comparison
For the Specialty Business Services subindustry, EnBio Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings Days Payable vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
EnBio Holdings's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EnBio Holdings (TSE:6092) has a Days Payable of 40.17 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on EnBio Holdings and its competitors. This is near median its historical median of 42.46. Over the past decade, EnBio Holdings' Days Payable has ranged from 32.36 to 51.45. According to the industry distribution chart, EnBio Holdings ranks #522 out of 946 companies in the Business Services industry, placing it in the top 55.2%.
Is EnBio Holdings' Days Payable too high?
EnBio Holdings' current Days Payable of 40.17 is near median its 10-year median of 42.46. Over the past 10 years, this metric has ranged from a low of 32.36 to a high of 51.45. The Business Services industry median Days Payable is 45.96. EnBio Holdings' value of 40.17 is 12.6% below this industry median. Based on the distribution chart, EnBio Holdings ranks #522 out of 946 companies in the Business Services industry, which is below the industry midpoint. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' Days Payable compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #522 out of 946 companies for Days Payable. This places EnBio Holdings in the lower half of its industry. The industry median Days Payable is 45.96. EnBio Holdings' value of 40.17 is 12.6% below this benchmark. Historically, EnBio Holdings' own Days Payable has ranged from 32.36 to 51.45 over the past decade. While the company's 10-year median is 42.46 vs. the industry median of 45.96, EnBio Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Business Services company?
The median Days Payable among Business Services companies is 45.96, based on 946 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EnBio Holdings's current Days Payable of 40.17 is 12.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median Days Payable is 45.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current Days Payable is 40.17, which is near median its own 10-year median of 42.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円799.37, compared to a current price of 円728.00 — trading 8.9% below its estimated fair value. The current Days Payable is 40.17, which is near median its 10-year median of 42.46 and 12.6% below the Business Services industry median of 45.96. EnBio Holdings' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current Days Payable is 40.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued.
The current stock price of 円728.00 is trading 8.9% below its estimated GF Value™ of 円799.37.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
Days Payable: 40.17 (near median its 10-year median of 42.46)
GF Value™: 円799.37 vs. price of 円728.00 (8.9% below fair value)
Industry Position: 12.6% below the Business Services median (#522 of 946)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
